Incidence and clinical characteristics of enterococcus keratitis

Cornea

Volumn 27, Issue 8, 2008, Pages 895-899

  Rau, Ganesh ^a,c   Seedor, John A ^a,b,c   Shah, Mahendra K ^b,c   Ritterband, David C ^a,c   Koplin, Richard S ^a,c  

^a Department of Ophthalmology ^*

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cornea; Enterococcus; Keratitis; Vancomycin

Indexed keywords

ANTIGLAUCOMA AGENT; CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN A; ERYTHROMYCIN; GATIFLOXACIN; IMIPENEM; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; STEROID; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CORNEA PERFORATION; CORNEA TRANSPLANTATION; DRUG SENSITIVITY; ENTEROCOCCAL INFECTION; ENTEROCOCCAL KERATITIS; ENTEROCOCCUS FAECALIS; EYE INJURY; FEMALE; GRAFT INFECTION; HUMAN; INCIDENCE; INFECTION RATE; KERATITIS; MALE; MEDICAL RECORD; MONOTHERAPY; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; SOFT CONTACT LENS; UNITED STATES; VISUAL ACUITY; BACTERIAL EYE INFECTION; BACTERIAL INFECTION; CORNEA ULCER; DRUG EFFECT; HYDROPHILIC CONTACT LENS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CONTACT LENSES, HYDROPHILIC; CORNEAL TRANSPLANTATION; CORNEAL ULCER; ENTEROCOCCUS FAECALIS; EYE INFECTIONS, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; KERATOPLASTY, PENETRATING; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEW YORK; RISK FACTORS; VANCOMYCIN;

EID: 50549084245     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31816f633b     Document Type: Article

References (29)

1. Teoh SC, Lee JJ, Chee CK, et al. Recurrent Enterococcus faecalis endophthalmitis after phacoemulsification. J Cataract Refract Surg. 2005; 31:622-626.
2. Scott IU, Loo RH, Flynn HW Jr, et al. Endophthalmitis caused by Enterococcus faecalis: antibiotic selection and treatment outcomes. Ophthalmology. 2003;110:1573-1577.
3. Nasrallah FP, Desai SA. Recurrent enterococcal endophthalmitis following cataract surgery: a case report. Ophthalmic Surg Lasers. 1999;30:481-482.
4. Oshitari K, Hirakata A, Okada AA, et al. Vitrectomy for endophthalmitis after cataract surgery. Nippon Ganka Gakkai Zasshi. 2003;107:590-596.
5. Busbee BG, Recchia FM, Kaiser R, et al. Bleb-associated endoph-thalmitis: clinical characteristics and visual outcomes. Ophthalmology. 2004;111:1495-1503.
6. Lee SM, Lee JH. A case of Enterococcus faecalis endophthalmitis with corneal ulcer. Korean J Ophthalmol. 2004;18:175-179.
7. Tuberville AW, Wood TO. Corneal ulcers in corneal transplants. Curr Eye Res. 1981;1:479-485.
8. Harris DJ, Stulting RD, Waring GO, et al. Late bacterial and fungal keratitis after corneal transplantation: spectrum of pathogens, graft survival, and visual prognosis. Ophthalmology. 1988;95:1450-1457.
9. Matoba AY. Polymicrobial keratitis secondary to Burkholderia ambifaria, Enterococcus, and Staphylococcus aureus in a patient with herpetic stromal keratitis. Am J Ophthalmol. 2003;136:748-749.
10. Sherman MD, Ostler HB, Biswell R, et al. Enterococcus faecalis infection in a corneal graft. Am J Ophthalmol. 1992;114:233-234.
11. Elhosn RR, Squires A, Emmert-Buck L, et al. Topical linezolid for the treatment of vancomycin resistant Enterococcus crystalline keratopathy after penetrating keratoplasty. Presented at the Annual Conference of the Association for Cataract and Refractive Surgeons, San Diego, CA, May 1-5, 2004.
12. Elitsur Y, Biedner BZ, Bar-Ziv J. Ethmoiditis, conjunctivitis, and orbital cellulitis due to Enterococcus infection. Clin Pediatr (Phila). 1984;23: 123.
13. Moellering R. Enterococcus species, Streptococcus bovis, and Leuconostoc species. In: Mandell, Bennett, Dolin, eds. Principles and Practice of Infectious Diseases. 6th ed., Churchill Livingstone; 2005: 2411-2417.
14. Mylonakis E, Engelbert M, Qin X, et al. The Enterococcus faecalis fsrB gene, a key component of the fsr quorum-sensing system, is associated with virulence in the rabbit endophthalmitis model. Infect Immun. 2002; 70:4678-4681.
15. Murray, PR. Manual of Clinical Microbiology, Washington, D.C. vols. 1 and 2. 8th ed. American Society for Microbiology.
16. Hodges TL, Zighelboim-Daum S, Eliopoulos GM, et al. Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens. Antimicrob Agents Chemother. 1992;36: 121-125.
17. Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 1998;4:239-249.
18. Rice LB. Antimicrobial resistance in Gram-positive bacteria. Am J Med. 2006;119:S11-S19.
19. National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470-485.
20. Zirakzadeh A, Patel R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc. 2006;81:529-536.
21. Esmaeli B, Holz ER, Ahmadi MA, et al. Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection. Retina. 2003;23: 118-119.
22. Levinson BA, Rutzen A. New antimicobials in ophthalmology. Ophthalmol Clin North Am. 2005;18:493-509.
23. Patterson JE. New gram-positive agents in nosocomial infection. Curr Opin Infect Dis. 2000;13:593-598.
24. Winston DJ, Emmanouilides C, Kroeber A, et al. Quinupristin/dalfopristin therapy for infections due to vancomycin-resistant Enteroccus faecium. Clin Infect Dis. 2000;30:790-797.
25. Linden PK, Moellering RC Jr, Wood CA, et al. Treatment of vancomycinresistant Enterococcus faecium infections with quinupristin/dalfopristin. Clin Infect Dis. 2001;33:1816-1823.
26. Vázquez EG, Mensa J, López Y, et al. Penetration of linezolid into the anterior chamber (aqueous humor) of the human eye after intravenous administration. Antimicrob Agents Chemother. 2004;48:670-672.
27. Fiscella RG, Lai WW, Buerk B, et al. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration. Ophthalmology. 2004;111:1191-1195.
28. Sader HS, Fritsche TR, Jones RN. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003). Diagn Microbiol Infect Dis. 2005;53: 329-332.
29. Jeu L, Fung HB. Daptomycin: a cyclic lipopeptide antimicrobial agent. Clin Ther. 2004;26:1728-1757.